NO
Nelson Obus
Director

Nelson Obus insider trades: Lifecore Biomedical, Inc. \de\ (LFCR) stock buys and sales

Director, Lifecore Biomedical, Inc. \de\ Last trade Oct 3, 2024 716 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
1,085
Open-market trades
since 2005
37
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Nelson reports to the SEC

and 31 more companies

Open-market buys and sales

1,085 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 3, 2024LFCR↑ Buy$696K
Oct 3, 2024LFCR↑ Buy$504K
Mar 13, 2024QRHC↑ Buy$109K
Mar 13, 2024QRHC↑ Buy$103K
Dec 11, 2023QRHC↑ Buy$27K
Dec 11, 2023QRHC↑ Buy$10K
Dec 8, 2023QRHC↑ Buy$20K
Dec 7, 2023QRHC↑ Buy$2K
Dec 6, 2023QRHC↑ Buy$7K
Dec 6, 2023QRHC↑ Buy$6K
Dec 5, 2023QRHC↑ Buy$29K
Dec 5, 2023QRHC↑ Buy$27K
Dec 4, 2023QRHC↑ Buy$697
Oct 31, 2023QRHC↑ Buy$4K
Oct 30, 2023QRHC↑ Buy$32K
Oct 30, 2023QRHC↑ Buy$19K
Oct 27, 2023QRHC↑ Buy$11K
Oct 26, 2023QRHC↑ Buy$45K
Oct 26, 2023QRHC↑ Buy$42K
Oct 25, 2023QRHC↑ Buy$7K
Oct 24, 2023QRHC↑ Buy$725
Oct 23, 2023QRHC↑ Buy$8K
Oct 23, 2023QRHC↑ Buy$8K
Oct 20, 2023QRHC↑ Buy$102K
Oct 20, 2023QRHC↑ Buy$23K
Oct 19, 2023QRHC↑ Buy$74K
Oct 18, 2023QRHC↑ Buy$94K
Oct 18, 2023QRHC↑ Buy$90K
Oct 17, 2023QRHC↑ Buy$1K
Oct 13, 2023QRHC↑ Buy$1K
Oct 12, 2023QRHC↑ Buy$9K
Oct 3, 2023QRHC↑ Buy$1K
Oct 2, 2023QRHC↑ Buy$32K
Oct 2, 2023QRHC↑ Buy$30K
Sep 8, 2023QRHC↑ Buy$10K
Sep 7, 2023QRHC↑ Buy$2K
Aug 31, 2023QRHC↑ Buy$3K
Aug 30, 2023QRHC↑ Buy$19K
Aug 30, 2023QRHC↑ Buy$18K
Aug 18, 2023QRHC↑ Buy$18K
Aug 18, 2023QRHC↑ Buy$8K
Aug 17, 2023QRHC↑ Buy$10K
Aug 15, 2023QRHC↑ Buy$48K
Aug 15, 2023QRHC↑ Buy$46K
Mar 14, 2023DLHC↓ Sell$2.4M
Mar 14, 2023DLHC↓ Sell$450K
Feb 28, 2023DLHC↑ Buy$55K
Feb 28, 2023DLHC↑ Buy$25K
Feb 7, 2023SANW↓ Sell$446K
Feb 7, 2023SANW↓ Sell$204K

The latest 1,000 of 1,085 trades can be shown here. Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Nelson Obus's insider trades

Nelson Obus is a director at Lifecore Biomedical, Inc. \de\ (LFCR). Since May 13, 2005, Nelson has reported 976 open-market purchases worth $328.3M and 109 sales worth $63.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (92 filings), option exercises (17 filings), other transactions (15 filings), shares returned to the company (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LFCR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.